Skip to content
Clinical Trials – home
Fundacio Assistencial De Mutua De Terrassa Fpc
Sponsor

Fundacio Assistencial De Mutua De Terrassa Fpc

Spain Calle De San Antonio No 32, 08221 Terrassa, Spain

About the sponsor

Research activity includes acute bacterial prostatitis caused by multidrug-resistant Escherichia coli, with interest in oral fosfomycin-trometamol and other antibiotic treatment options for resistant urinary tract infections.

  • Multidrug-resistant E. coli
  • Acute bacterial prostatitis
  • Oral fosfomycin

The sponsor’s infectious disease portfolio is centered on bacterial prostatitis and the management of antimicrobial resistance in urological infection.

About Specializations

Fundacio Assistencial De Mutua De Terrassa Fpc runs clinical trials in conditions such as Bacterial prostatitis, Prostatitis Escherichia coli, Dyspnoea, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Bacterial prostatitis+1

Not yet recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin
  • Sponsor:Fundacio Assistencial De Mutua De Terrassa Fpc

Dyspnoea

Not yet recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Fentanyl
  • Sponsor:Fundacio Assistencial De Mutua De Terrassa Fpc

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).